✦ LIBER ✦

Dopamine D2 receptor density remains constant in treated Parkinson's disease

✍ Scribed by Mark Guttman; Dr Philip Seeman; Gavin P. Reynolds; Peter Riederer; Kurt Jellinger; Wallace W. Tourtellotte

Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 780 KB
Volume: 19
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.410190510

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dopamine D2 receptor TaqIA and TaqIB pol

Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease

✍ Eng-King Tan; Yanni Tan; Anthea Chai; Christopher Tan; Hui Shen; Sau-Ying Lum; S 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB 👁 1 views

## Abstract In a case control study, we examined the association of DRD2 Taq1A and Taq1B polymorphisms and risk of PD, and evaluated the strength of linkage disequilibrium of the polymorphisms. The Taq1A and Taq1B polymorphisms were in strong linkage disequilibrium. There was, however, no significa

Dopamine D2 receptor TaqI A polymorphism

Dopamine D2 receptor TaqI A polymorphism and Parkinson's disease

✍ Mario Zappia; Grazia Annesi; Aldo Quattrone 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 9 KB

We read with interest the article by Grevle and colleagues, 1 reporting in Norway an association between the variant allele A1 of the TaqI A restriction fragment length polymorphism (RFLP) located in the dopamine D2 receptor (DRD2) gene and Parkinson's disease (PD). Similar findings have been report

Insular dopamine D2 receptors and novelt

Insular dopamine D2 receptors and novelty seeking personality in Parkinson's disease

✍ Valtteri Kaasinen; Sargo Aalto; Kjell Någren; Juha O. Rinne 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

## Abstract Novelty seeking is a temperament trait characterized by impulsiveness and exploratory behavior. Dopamine has been suggested to be the primary neurotransmitter modulator of novelty seeking, and in young healthy subjects, a correlation between increased novelty seeking and decreased insul

Extrastriatal dopamine D2 receptor bindi

Extrastriatal dopamine D2 receptor binding in Huntington's disease

✍ Mouna Esmaeilzadeh; Lars Farde; Per Karlsson; Andrea Varrone; Christer Halldin; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 430 KB

## Abstract Huntington's disease (HD) is a neurodegenerative disorder, primarily affecting medium spiny neurones in the striatum. The density of striatal dopamine D~2~ receptors is reduced in HD but there is little known about this biomarker in brain regions outside the striatum. The primary object

The dopamine D2 receptor gene is a susce

The dopamine D2 receptor gene is a susceptibility locus for Parkinson's disease

✍ Rosario L. Oliveri; Grazia Annesi; Mario Zappia; Donatella Civitelli; Elvira V. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB 👁 2 views

The risk of valvular regurgitation in pa

The risk of valvular regurgitation in patients with Parkinson's disease treated with dopamine receptor agonists

✍ Vibeke Guldbrand Rasmussen; Karen Østergaard; Erik Dupont; Steen Hvitfeldt Pouls 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB 👁 1 views

## Abstract ## Objectives: Several observational studies suggest an association between treatment with ergoline‐derived dopamine agonists and valvular regurgitation. In this article, we present an overview of the literature and conduct a meta‐analysis. ## Methods: Observational studies addressin